Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

'Natural Daegu', the rising city of eco-tourism

DAEGU, South Korea, June 10, 2019 /PRNewswire-AsiaNet/ -- The city of Daegu is celebrating '2020-the year of Tourism in Daegu and Gyeongbuk' by creating the new brand 'Natural Daegu' to prom...

Must-see Masterpieces, Craftworks Featuring Spring to Be Displ...

TOKYO, Feb. 14, 2019 /Kyodo JBN-- AsiaNet/ -- The National Museum of Modern Art, Tokyo, Japan's first national art museum situated at Kitanomaru Park neighboring the Imperial Palace, will ho...

Media Experts: Telling Hainan's Beautiful Story through Intern...

HAIKOU, China, Sept. 7, 2018 /Xinhua-AsiaNet/-- In late August, international communication experts gathered in Haikou City, Hainan Province. They were invited to a seminar themed "Innovatin...

CGTN: Hand in Hand: China calls for multilateralism to tackle ...

BEIJING, Jan. 26, 2021 /PRNewswire-Asianet/ -- Against the backdrop of a pandemic that has taken tolls on global public health and put the world economy in deep recession, the world in 2020 ...

Face Up To Rosacea: Galderma Launches Online Support to Empowe...

LAUSANNE, Switzerland, Oct. 21, 2019 /PRNewswire-AsiaNet /-- New 'Face up to rosacea' campaign comprising online content and a downloadable, personalized patient appointment guide, equips pe...

Euroclear: Directorate Changes

BRUSSELS, June 19, 2020 /PRNewswire-AsiaNet/ -- The Euroclear group announces that Marc Antoine Autheman has decided to step down as the Chairman and Director of the Euroclear boards.During ...

CÉ LA VI Singapore Presents a New Year's Eve Extravaganza to Ring in 2024

Step into 2024 with a series of New Year's Eve events at CÉ LA VI Singapore, featuring a crafted brunch, special dinner menu, and a gold-themed countdown party.SINGAPORE - Media OutR...

IAmCasting Revolutionizes Media Industry with Launch of New Casting App at 10th Singapore Media Festival

Connecting Asian talents, models, actors, celebrities, singers, content creators, sports stars, and performers to limitless opportunities worldwideSINGAPORE - Media OutReach Newswire - 7 De...

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

SYDNEY, Apr 8, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

View and Download the COVID-19 Australia Data Bulletin here. https://novotech-cro.com/covid-19-notice

The data is part of a new series prepared for Novotech clients detailing the current status of trials in the Asia-Pacific during the global COVID-19 crisis.

Novotech CEO Dr John Moller said the Bulletin series taps local knowledge of fundamentals in the sector and shows which countries in the region are able to support clinical research for Novotech and its clients during this time.

"While the situation is always evolving, Australia appears to be managing the crisis well. Our sites have changed how they manage trials in line with Australian Government health guidelines and most are still able to deliver the clinical trial services we need for our clients," said Dr Moller. "Study delays caused by COVID-19 can be rapidly addressed by activating new sites in Australia and Asia."

Australia has attractive start-up times, world leading investigators and research teams, and valuable rebates of up to 43.5% on clinical trial spend.

About Novotech

Novotech, established in 1996, is internationally recognized as the leading full-service contract research organization (CRO) in Asia-Pacific. Novotech provides clinical development services across all clinical trial phases and therapeutic areas and has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotech companies.

Novotech obtained the ISO 27001, the best-known standard in the ISO family, providing the requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies. Visit http://novotech-cro.com.

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

Media ContactSusan Fitzpatrick-Napiercommunications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastStreamEastjojobetcialis 20 mg fiyat